SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+1.62%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.56B
AUM Growth
+$524K
(+0.03%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
8.34%
Top 10 Holdings %
Top 10 Hldgs %
60.82%
Holding
82
New
11
Increased
20
Reduced
11
Closed
11
Top Buys
| 1 |
Regenxbio
RGNX
|
$28.8M |
| 2 |
Xencor
XNCR
|
$21.5M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$20.9M |
| 4 |
iRhythm Technologies
IRTC
|
$19.9M |
| 5 |
Guardant Health
GH
|
$19.3M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$67.8M |
| 2 |
United Therapeutics
UTHR
|
$20M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$15.8M |
| 4 |
Zoetis
ZTS
|
$14.8M |
| 5 |
Exelixis
EXEL
|
$10.3M |
Sector Composition
| 1 | Healthcare | 93.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTX
26
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $14.2M | 0.83% |
3,083,712
| – | – |
|
|
INZY
27
DELISTED
Inozyme Pharma
INZY
| $13.8M | 0.81% |
2,028,308
| – | – |
|
28
Immatics
IMTX
$656M
| $13.8M | 0.81% |
1,026,623
+548,407
| +115% | +$7.37M |
|
29
Bolt Biotherapeutics
BOLT
$9.41M
| $13.5M | 0.79% |
137,722
| – | – |
|
|
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $13.4M | 0.78% |
798,789
+441,389
| +124% | +$7.38M |
|
|
NCNA
31
NuCana
NCNA
$5.38M
| $13.3M | 0.78% |
1,120
| – | – |
|
|
JNCE
32
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $13.2M | 0.77% |
1,582,777
+945,430
| +148% | +$7.89M |
|
|
IMGN
33
DELISTED
Immunogen Inc
IMGN
| $13M | 0.76% |
+1,749,882
| New | +$13M |
|
|
AKUS
34
DELISTED
Akouos, Inc. Common Stock
AKUS
| $12.9M | 0.75% |
1,515,074
| – | – |
|
35
Insmed
INSM
$30B
| $12M | 0.7% |
441,773
-93,347
| -17% | -$2.54M |
|
36
Fulcrum Therapeutics
FULC
$365M
| $10.9M | 0.64% |
617,670
+566,664
| +1,111% | +$10M |
|
37
Sarepta Therapeutics
SRPT
$1.92B
| $10.9M | 0.64% |
120,732
-36,547
| -23% | -$3.29M |
|
38
Celldex Therapeutics
CLDX
$1.5B
| $10.5M | 0.61% |
271,533
+134,501
| +98% | +$5.2M |
|
|
CMPI
39
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $10.4M | 0.6% |
3,606,707
| – | – |
|
40
uniQure
QURE
$931M
| $10.3M | 0.6% |
495,025
+416,283
| +529% | +$8.63M |
|
|
OBSV
41
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $9.45M | 0.55% |
4,749,623
| – | – |
|
42
BioMarin Pharmaceuticals
BMRN
$10.9B
| $7.72M | 0.45% |
+87,322
| New | +$7.72M |
|
43
Zymeworks
ZYME
$1.07B
| $6.44M | 0.38% |
392,712
-17,907
| -4% | -$294K |
|
|
AGEN
44
Agenus
AGEN
$132M
| $6.32M | 0.37% |
99,915
-19,533
| -16% | -$1.23M |
|
45
InflaRx
IFRX
$108M
| $5.53M | 0.32% |
+1,161,736
| New | +$5.53M |
|
46
Adicet Bio
ACET
$59.7M
| $5.44M | 0.32% |
+310,988
| New | +$5.44M |
|
47
PTC Therapeutics
PTCT
$4.46B
| $5.28M | 0.31% |
132,448
-97,571
| -42% | -$3.89M |
|
48
Kura Oncology
KURA
$700M
| $5.17M | 0.3% |
369,173
-385,948
| -51% | -$5.4M |
|
|
SRRA
49
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.62M | 0.27% |
212,281
+5,717
| +3% | +$124K |
|
|
ITCI
50
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.98M | 0.17% |
56,915
-170,504
| -75% | -$8.92M |
|